TTK Healthcare share news, announcements and annual reports
NSE: TTKHLTCAREBSE: 507747DiversifiedSmall Cap
TTK Healthcare Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Jan 1987 on BSE, Jul 2010 on NSE
Last close ₹914.25up ₹8.95 (0.99%)BSE ₹913.80
Share price at the NSE close on 2 Nov 2026. Previous close ₹905.30.
2 Nov: open ₹905.05, high ₹924.95, low ₹891.25
52-week range of traded prices to 2 Nov 2026
₹735.00Low, 30 Mar 2026₹1,247.00High, 9 Sep 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹1,292 Cr1,358th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 4.67
- P/E without one-offsPrice to earnings without one-off items. Market cap divided by core profit: the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, less one-off items (exceptional items and the result of businesses sold or closed). Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹244 crore of one-off items, the largest of them in the quarter to Sep 2026.
- 39.85
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 0.96
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 1.09%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 22.7%
- ROE without one-offsReturn on equity without one-off items. Core profit, the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders less one-off items (exceptional items and the result of businesses sold or closed), as a percentage of the same net worth as the return on equity. Shown where the one-off items move that profit by more than a tenth. The last twelve months' profit includes ₹244 crore of one-off items, the largest of them in the quarter to Sep 2026.
- 2.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 2.0%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.02
- Volume, NSEVolume. Shares traded on the last trading day; delivery is the part buyers kept rather than sold again the same day. Volume in the glossary
- 14,22249.9% delivered
TTK Healthcare share news and announcements
592 announcements, routine notices left out, newest first. Page 11 of 12.
Apr 2016
Feb 2016
Jan 2016
Dec 2014
Nov 2014
3 Nov · Updates
Trading window for dealing in the shares of the Company will remain closed from 31st October 2014 to 5th November 2014 (both days inclusive) as per Regulation 3.2.1 of SEBI (Prohibition of Insider Trading) Regulations 1992 and the Company's Code of Conduct for Prevention of Insider Trading (Source MSE)
Oct 2014
17 Oct · Board meeting
Iner alia, to consider and approve the unaudited financial results for the second quarter ended 30th September 2014 (Source MSE)
Sep 2014
Aug 2014
25 Aug · Disclosure of Voting Pattern - Clause 35A
25 Aug · Delisting
Board of Directors, at its meeting held on 22nd August 2014. approved the proposal for delisting of equity shares of the Company from Madras Stock Exchange Ltd. The Company has further confirmed that the equity shares of the Company will continue to remain listed on BSE, which has nationwide trading terminal. (Source MSE)25 Aug · Board meeting
Board of Directors, in their meeting held on 22nd August 2014, confirmed the appointment of the existing managerial personnel as follows: (1) Mr. T. T. Raghunathan, Executivd Vice Chairman as the Chief Executive Officer (CEO) (2) Mr. S. Kalyanaraman, President - Commercial & Company Secretary as Company Secretary; and (3) Mr. B V K Durga Prasad, Senior Vice President - Finance as Chief Financial Officer (CFO) as Key Managerial Personnel of the Company in accordance with the provisions of section 203 of the Companies Act 2013 and the Rules made thereunder. (Source MSE)25 Aug · Management
Board of Directors, in their meeting held on 22nd August 2014, co-opted Mr. S. Kalyanaraman, the Wholetime Secretary, as an Additional Director on the board, liable to retire by rotation, with effect from 1st September 2014. (Source MSE)25 Aug · Disclosure of Voting Pattern - Clause 35A
1 Aug · Management
That Mr. K Vaidyanathan, Executive Director of the Company, has expressed his desire to retire from the position of Executive Director / Director of the Company, with effect from September 01, 2014, vide his communication dated August 01, 2014. Accordingly, he will be relieved from the position of Executive Director / Director of the Company, at the start of working hours on September 01, 2014. (Source MSE)
Jul 2014
30 Jul · Others
In connection with the declaration of quarterly financial results, the Trading Window for dealing in the shares of the Company will remain closed from 29th July 2014 to 2nd August 2014 (both days inclusive), as per Regulations 3.2.1 of SEBI (Prohibition of Insider Trading) Regulations 1992 and Company's Code of Conduct for Prevention of Insider Trading (Source MSE)23 Jul · Meeting
The 56th Annual General Meeting of the Company has been scheduled on 22nd August 2014 and the Register of Members and the Share Transfer Books of the Company will remain closed from 19th August 2014 to 22nd August 2014 (both days inclusive) for the purpose of holding the said Annual General Meeting and declaration of dividend. The Company has further informed that the dividend, if declared at the said Annual General Meeting, will be distributed on 11th September 2014. (Source MSE)18 Jul · Board meeting
Inter alia, to consider and approve the unaudited financial results for the first quarter ended 30th June 2014 (Source MSE)
Jun 2014
11 Jun · Legal
Spurt in Volume : Substantial increase in trading volumes have been observed in TTK Healthcare Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. TTK Healthcare Limited has vide its letter inter-alia stated, " We, as of now, do not have any information / announcement about our Company which in our opinion may have a bearing on the price / volume behaviour in the scrip." (Source MSE)
May 2014
27 May · Dividend
Board of Directors of the Company at its meeting held on 27th May 2014, has recommended a Dividend of Rs. 4/- per Equity Share of Rs. 10/- each (40%) for the financial year ended 31st March 2014 which shall be paid on the 21st day from the conclusion of the Annual General Meeting, subject to the approval of the Shareholders of the Company. (Source MSE)20 May · Others
Trading Window for dealing in the shares of the Company will remain closed from 21st May, 2014 to 28th May, 2014, as per Regulation 3.2.1 of SEBI (Prohibition of Insider Trading) Regulations,1992 and Company's Code of Conduct for Prevention of Insider Trading, in connection with the Board Meeting to be held on 27th May 2014 for considering Audited Financial Results. (Source MSE)
Apr 2014
28 Apr · Board meeting
Inter alia , to consider and approve the Audited Financial Results of the Company for the year ended 31st March 2014. (Source MSE)
Mar 2014
20 Mar · Disclosure of Voting Pattern - Clause 35A
Feb 2014
Jan 2014
31 Jan · Others
Trading Window for dealing in the shares of the Company will remain closed from 31st January, 2014 to 07th February, 2014, as per Regulation 3.2.1 of SEBI (Prohibition of Insider Trading) Regulations,1992 and Company's Code of Conduct for Prevention of Insider Trading, in connection with the Board meeting to be held on 5th February 2014 for considering the unaudited financial results for 31st December 2013. (Source MSE)16 Jan · Board meeting
Inter alia, to consider and approve the Unaudited Financial Results of the Company for the Third Quarter ended 31st December 2013. (Source MSE)
Nov 2013
Oct 2013
7 Oct · Board meeting
Inter alia, to consider and approve the Un-audited Financial Results of the Company for the Second Quarter ended 30th September 2013. (Source MSE)
Sep 2013
Aug 2013
Jul 2013
29 Jul · Disclosure of Voting Pattern - Clause 35A
15 Jul · Board meeting
Inter alia, to consider and approve the Un-audited Financial Results of the Company for the first quarter ended 30th June 2013. (Source MSE)
Jun 2013
May 2013
29 May · Meeting
The 55th Annual General Meeting of the company has been scheduled to be held on 25th July 2013 and the Register of Members and the Share Transfer Books of the Company will remain closed from 18th July 2013 to 25th July 2013 (Both days inclusive). (Source MSE)29 May · Management
Board of Directors of the Company at their meeting held on 27th May 2013, re-appointed Mr. K Vaidyanathan, Executive Director, for a further period of two years, with effect from 1st July 2013. (Source MSE)28 May · Dividend
Board, at its meeting held on 27th May 2013, recommended a Dividend of Rs. 4/- per equity shares of Rs. 10/- each (40%) for the financial year ended 31st March 2013. (Source MSE)15 May · Board meeting
Inter-alia, to consider and approve the Audited Financial Results of the Company for the year ended 31st March 2013 and recommendation of dividend, if any. (Source MSE)
Apr 2013
12 Apr · Legal
Spurt in Volume : Substantial increase in trading volumes have been observed in TTK Healthcare Limited.. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. TTK Healthcare Limited has vide its letter inter-alia stated,"We would like to inform you that we, as of now, do not have any information/announcement about our Company which in our opinion may have a bearing on the price/volume behaviour in the scrip." (Source MSE)10 Apr · Updates
Company is proposed to publish the Audited Financial Results for the financial year ended 31st March 2013 along with the Audited Financial Results for the Fourth Quarter ended 31st March 2013 on or before 30th May 2013 (within 60 days from the end of the financial year ended 31st March 2013). (Source MSE)
Feb 2013
1 Feb · Updates
Mr. T T Raghunathan, in addition to his existing responsibility as Executive Vice Chairman of the Company, has been appointed as the Managing Director of M/s TTK Protective Devices Limited (formerly M/s. TTK-LIG Limited), with effect from 1st February, 2013. He ha also relinquished his Office as Managing Director of M/s. TTK Tantex Limited. (Source MSE)
Jan 2013
10 Jan · Board meeting
Inter alia, to consider and approve the Un-audited Financial Results of the Company for the Third Quarter ended 31st December 2012. (Source MSE)